Last updated: August 17, 2026

Examiner: HIBSHMAN, SARAH GRACE

Tech Center 1600 • Art Units: 1623 1693

This examiner grants 39% of resolved cases

Performance Statistics

38.8%

Allow Rate

-21.2% vs TC avg

Total Applications

+43.8%

Interview Lift

1252

Avg Prosecution Days

Based on 49 resolved cases, 2023–2026

3.4%

§101 Eligibility

17.0%

§102 Novelty

39.0%

§103 Obviousness

25.6%

§112 Clarity

App #	Title	Status	Assignee
18249515	COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC CONDITIONS	Non-Final OA	The Regents of the University of California
17599282	XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF	Non-Final OA	THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
17614407	A MEDICAMENT FOR TREATING MYCOBACTERIAL INFECTION CHARACTERIZED BY COMBINING A CYTOCHROME bc1 INHIBITOR WITH CLARITHROMYCIN OR AZITHROMYCIN AND CLOFAZIMINE	Final Rejection	HSIRI THERAPEUTICS, INC.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.